Tagged with Pharma,

Switzerland Backed by the Japanese Zeria Group, fast growing gastrointestinal (GI) specialist Tillotts Pharma is looking to acquire further GI assets after its recent USD 200m M&A deal. The company is looking for assets which generate a turnover of EUR 50 – 150 million in Europe and/or Japan, and also to…

Mexico Xavier Rams, General Director at Ferrer Mexico, explains the importance of aligning corporate strategy to public healthcare goals in order to succeed in the dynamic Mexican environment and showcases the added value that Sincronium® creates for the national healthcare system as a whole. You have been in charge of Ferrer…

Greece Ioanna Koukli, the owner and founder of Pharmassist Ltd, began the company with a vision of assisting healthcare companies manoeuver through the European regulatory milieu. Today, with Pharmassist established as a full service CRO, Koukli discusses the company’s evolution, the potential of clinical trials in Greece, as well as fostering…

Taiwan Freddie Höglund, CEO of the European Chamber of Commerce Taiwan (ECCT), and Mike Exton, Managing Director of Novartis Taiwan and Co-Chair of the Pharmaceutical Committee of the ECCT, document the main issues at stake for the international pharmaceutical companies implanted in Taiwan, while providing us with a broader overview of…

Greece The management team of PharOS discuss the company’s move from generics consultancy to co-developer, surviving in the Greek market, and internationalization plans. Founded back in 2002, PharOS has gained a formidable reputation as a pharma development company for bringing best in class generics products to market and prolonging their life…

Taiwan Mike Exton, Managing Director at Novartis Taiwan, describes the affiliate’s plans to increase collaboration with the government in order to provide Taiwanese patients with a greater access to innovative, life-changing products, while highlighting Novartis’ world-class innovation in many critical therapeutic areas, such as heart failure, as well as the skilled…

Ireland The UK’s decision to leave the EU in Summer 2016 sent shockwaves throughout Europe and left neighbouring countries struggling to interpret what ‘Brexit’ means for them. Ireland, as the UK’s closest neighbour both culturally and geographically, could stand to benefit from the decision in the medium- to long-term, especially in…

Greece John Kandylis, GM of Greek logistics market leader Olympias, discusses his company’s unique service offering, negotiating the issues brought about by the financial crisis, and retaining a family-run spirit while expanding internationally. Olympias SA is positioned as a market leader in logistics with deep expertise in the field. Could you…

Taiwan Petar Vazharov, Alvogen’s executive vice president for Asia Pacific, and, Jefferson Wang, general manager of Lotus, provide insights into Lotus’ tremendous evolution from a local generics company into a regional player holding international ambitions, and highlight the main achievements of this fast-growing company since it joined the Alvogen group in…

Switzerland The global leader in the specialized niche of micronization services, Jetpharma is set for continued steady growth driven by the continued development of extremely dangerous-to-handle highly potent active ingredients. To begin, could you please introduce Jetpharma and the field of micronization to our readers? “Jetpharma has over 40 years of…

Greece Despite the difficulties of the financial crisis and subsequent austerity legislation, pharma firms implanted in Greece have nonetheless continued to exhibit great commitment and staying power. “The big multinationals have not been panicking and resorting to large-scale layoffs or fleeing the market.” Konstantinos Kofinas, Merck “Regardless of the challenges posed…

Greece Compassion resonates through the voice of Marianna Konstantinidi, General Manager of CSL Behring Greece, Malta & Cyprus, as she speaks about the resilient and patient-centric operations of the Greek affiliate. She graciously shares her views regarding her first impressions of the plasma market, the challenging environment in Greece, as well…